glp-1 therapy kenner GLP-ONE + Receptor Activator Obesity is a chronic condition,

Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al

In addition to blunted monoaminergic neurotransmission, it was also shown that deficiency in neurotrophic factor effects, disturbances in neurogenesis and synaptogenesis, chronic neuroinflammatory processes, and dysregulation of the hypothalamicpituitaryadrenal (HPA) axis can largely contribute to the manifestation of depressive symptoms in patients [3,4,5]

The speed at which your blood sugar improves can influence your eye risk as much as the medications themselves

In early 2025, Eli Lilly launched a direct-to-consumer platform called LillyDirect

In company-reported late-phase maintenance data, patients in SURMOUNT-MAINTAIN first lost weight on higher-dose Zepbound, then either continued the maximum tolerated dose or stepped down to 5 mg for a maintenance year